Bruce N. Jacobs, Chief Financial Officer at Kymera Therapeutics, Inc. (KYMR), sold 20,000 shares at $46.66 ($937K) on 2021-06-03, disclosed to the SEC on 2021-06-04.
Open-market sale of $937k KYMR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.66 | 5,506 | $257K | 27.4% |
| 2 | $46.66 | 5,506 | $257K | 27.4% |
| 3 | $47.13 | 4,494 | $212K | 22.6% |
| 4 | $47.13 | 4,494 | $212K | 22.6% |
| Total | $46.87 avg | 20,000 | $937K | 100% |
| Filing → |
| KYMR | SELL | 2025-09-17 | $4.0M | — | Filing → |
| KYMR | SELL | 2025-03-03 | $389K | — | Filing → |
| KYMR | SELL | 2024-03-04 | $318K | — | Filing → |